Ignite Creation Date:
2025-12-25 @ 1:59 AM
Ignite Modification Date:
2025-12-26 @ 3:55 AM
Study NCT ID:
NCT03386994
Status:
COMPLETED
Last Update Posted:
2020-11-09
First Post:
2017-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study
Sponsor:
Boehringer Ingelheim
Organization:
Study Overview
Official Title:
Observational Analysis on the Socio-economic Impact of IPF in Spain
Status:
COMPLETED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Descriptive prospective non-interventional multicenter study based on newly collected data of Idiopathic Pulmonary Fibrosis patients followed-up for one year in secondary care settings (Pulmonology Services)
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: